Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.053 | 0.7 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.066 | 0.7 |
mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |